Apollo Hospitals and Devyani International: Nuvama Predicts 20-30% Upside Despite Recent Dips

Despite recent share price drops, Nuvama remains bullish on Apollo Hospitals and Devyani International, projecting 20-30% upside potential. Apollo Hospitals reported strong Q3 FY25 results with a 51.8% YoY profit increase to ₹372.3 crore, despite a 7% share price dip. Devyani International, while posting a ₹7.65 crore Q3 loss, saw 53% YoY revenue growth to ₹1,294.4 crore. Analysts cite Apollo's expansion plans and Devyani's KFC growth as key drivers. Both stocks present attractive opportunities in the healthcare and QSR sectors for long-term investors.

 

Sources: Economic Times, Moneycontrol, Fortune India